Effect of rifampicin on stability and transfer of R-factors
✍ Scribed by Dr. V. Krčméry; J. Janoušková
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 315 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0233-111X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Rifampicin LEPETIT, an antibiotic known to interfere with the activity of DNA‐dependent bacterial RNA polymerase, prevented the conjugational transfer of R‐factors in Salmonella typhimurium and Escherichia coli, and showed appreciable accumulation of R— variants in R^+^ cultures. The drug was active in concentrations from 0.25 to 5.0 μg/ml while there was no influence on the viable count of the R^+^ cultures. Although the concentrations of rifampicin found to be active in R^+^ strains of enterobacteria are about 10 times higher than those found to be active in staphylococci by JOHNSTON and RICHMOND (1970), the sub‐bacteriostatic concentrations of the drug were effective enough to eliminate R‐factors and to prevent their transfer from the donor cells studied.
📜 SIMILAR VOLUMES
## Abstract Rifampicin has a marked inhibitory effect on Rauscher‐virus‐induced leukaemia. Up to 90% inhibition of splenomegaly can be achieved when the drug is administered immediately after infection. It is suggested that these results may have implications for a rational leukaemia therapy.
Tuberculosis chemotherapy involves combination of the drugs isoniazid (INH), rifampicin (RMP) and pyrazinamide (PYR) for a 6-month period. The present work investigated the influence of RMP and PYR on the pharmacokinetic parameters of INH when groups of rats were pre-treated for 21 days with INH alo